# EMSAM
> **NDA021708** · New Drug Application · Sponsor: SOMERSET · Approved 2006-02-27
## Drug
- **FDA Application Number:** NDA021708
- **Application type:** New Drug Application
- **Brand name:** EMSAM
- **Generic name:** Selegiline
- **Active ingredients:** SELEGILINE
- **Dosage form:** SYSTEM
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET
- **First approval:** 2006-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021708)
---
*AI Analytics · CC0 1.0*